Tekla Harju (Tekla Järviaho)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Ejection Fraction

Acute Lymphoblastic Leukemia

Dna Methylation

Top Venues

The pharmacogenomics journal

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Tekla Harju, Anri Hurme-Niiranen, Maria Suo-Palosaari, Stine Nygaard Nielsen, Reetta Hinttala, Kjeld Schmiegelow, Johanna Uusimaa, Arja Harila, Riitta Niinimäki
DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia: is there a causal relationship? The pharmacogenomics journal (2023)
Tekla Harju, Benedicte Bang, Vasilios Zachariadis, Fulya Taylan, Jukka S Moilanen, Merja Möttönen, Carl Inge Edvard Smith, Arja H Harila-Saari, Riitta Niinimäki, Ann Nordgren
Predisposition to childhood acute lymphoblastic leukemia caused by a constitutional translocation disrupting ETV6. Blood advances 3 (18) (2020)
Tekla Harju, Vasilios Zachariadis, Bianca Tesi, Samuel Chiang, Yenan T Bryceson, Merja Möttönen, Riitta Niinimäki, Benedicte Bang, Elisa Rahikkala, Fulya Taylan, Johanna Uusimaa, Arja Harila-Saari, Ann Nordgren
Microdeletion of 7p12.1p13, including IKZF1, causes intellectual impairment, overgrowth, and susceptibility to leukaemia. British journal of haematology 185 (2) (2018)